Beta-propiolactone as a sterilizing agent in the manufacture of intravenous immunoglobulin preparations
Stephan, W.; Dichtelmüller, H.
Arzneimittel-Forschung 33(9): 1230-1231
1983
ISSN/ISBN: 0004-4172 PMID: 6416260 Document Number: 217351
It was demonstrated with phi X174, phi e and x phages that the beta-propiolactone step, which eliminated the anticomplementary activity of the intravenous immunoglobulin (IgG) preparation. Intraglobin, inactivates more than 10(6) viruses/ml. This means additional safety with respect to those viral diseases for which specific and sensitive diagnostic methods are not available at present.
Document emailed within 1 workday
Related Documents
Stĕpánek, J.; Mensík, J.; Pospísil, Z.; Rozkosný, V. 1973: Effect of formaldehyde and beta-propiolactone on the infectivity and antigenicity of the causative agent of viral gastroenteritis of swing (VGS) Veterinarni Medicina 18(5): 269-280Rüfenacht, R.; Morell 1991: Immunochemical characterization of intravenous immunoglobulin preparations Allergologia et Immunopathologia 19(5): 197-200
Nydegger, U.E. 1983: Evaluation criteria for intravenous immunoglobulin G preparations Presse Medicale 12(41): 2619-2624
Guencheva, G. 1984: Requirements and characteristics of various immunoglobulin preparations for intravenous application Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 30(1): 21-23
Siwińska-Gołebiowska, H.; Czerwińska-Kartowicz, I.; Markiewicz, K. 2002: Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies Postepy Higieny i Medycyny Doswiadczalnej 56 Suppl: 33-40
Kiseleva, I.A.; Anastasiev, V.V.; Novikova, L.P.; Voronova, E.A.; Kartavina, G.I. 1990: Elaboration of the technology of producing a lyophilized form of immunoglobulin preparations for intravenous administration Gematologiia i Transfuziologiia 35(5): 32-34
Stephan, W.; Kotitschke, R.; Prince, A.M.; Brotman, B. 1981: Long-term tolerance and recovery of beta-propiolactone/ultraviolet (beta PL/UV) treated PPSB in chimpanzees Thrombosis and Haemostasis 46(2): 511-514
Buchacher, A.; Krause, D.; Wiry, G.; Weinberger, J. 2010: Elevated Endotoxin Levels in Human Intravenous Immunoglobulin Concentrates Caused by (1->3)-{beta}-D-Glucans PDA Journal of Pharmaceutical Science and Technology 64(6): 536-544
Nürnberger, W.; Willers, R.; Körholz, D.; Göbel, U.; Wahn, V. 1988: Preventive long-term intravenous immunoglobulin infusion in children with acute lymphatic leukemia. I. Anticomplementary activity of gamma globulin preparations is a function of the preparation and IgG concentration prior to infusions Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 136(3): 116-120
Fukuda, S.; Yamamoto, N. 1970: Effect of beta-propiolactone on bacteriophages and Salmonella typhimurium Cancer Research 30(3): 830-833
Sonneborn, H.H.; Stephan, W. 1980: Tolerance of beta-propiolactone-treated and UV-irradiated rat serum Infusionstherapie und Klinische Ernahrung 7(3): 145-147
Mathew, T.; Chowdhuri, A.N.; Bhola, S.R.; Topa, P.K. 1978: Studies on beta-propiolactone inactivated suckling mouse brain antirabies vaccine Indian Journal of Medical Research 68: 197-203
Bourguignon, C.; Celine, B.; Grain, A.; Amandine, G.; Schlatter, J.; Joel, S.; Vermerie, N.; Norbert, V. 2005: Permeation risks with peracetic acid and hydrogen peroxide sterilizing agent inside ambulatory pumps PDA Journal of Pharmaceutical Science and Technology 59(3): 200-205
Lombardi, D. 1966: Comparative tests of inactivation and antigenicity of the Newcastle virus treated with beta-propiolactone and with formol Rivista Dell'istituto Sieroterapico Italiano 41(1): 11-21
Börner, P.; Deicher, H.; Bähr, I.; Chalius, H.H.; Ghani, G.; Geldmacher, H.; Henke, I.W.; Kindermann, L.; Marks, V. 1976: Prophylatic rhesus sensitization via intravenous administration of immunoglobulin G anti-D. III. Limits of the prophylaxsis obtainable by adapting the immunoglobulin dosage to the extent of the fetalmaternal blood transfusion Geburtshilfe und Frauenheilkunde 36(6): 485-492
Karpliuk, I.A.; Gogol', A.T. 1978: Hygienic aspects of the use of smoking preparations in the manufacture of meat products Voprosy Pitaniia 5: 16-19
Budovskiĭ, E.I.; Zalesskaia, M.A. 1985: Principles of selective inactivation of the viral genome. III. Kinetics of the inactivation of bacteriophage MS2 infectivity by beta-propiolactone Molekuliarnaia Biologiia 19(4): 1139-1147
Pilenkova, I.I.; Iurkova, R.G. 1981: Method for the separate determination of atrazine, prometryne and simazine in the air during the manufacture of the combination preparations agelon and sitrin Gigiena Truda i Professional'nye Zabolevaniya (7): 51-52
Naess, K. 1973: A beta blocking agent as an antihypertensive agent Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(27): 2041
Villiers, V. 1975: Immunoglobulin preparations South African Medical Journal 49(31): 1249-1251